These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 18418805)

  • 21. Vaccine-strain varicella zoster virus causing recurrent herpes zoster in an immunocompetent 2-year-old.
    Ota K; Kim V; Lavi S; Ford-Jones EL; Tipples G; Scolnik D; Tellier R
    Pediatr Infect Dis J; 2008 Sep; 27(9):847-8. PubMed ID: 18664930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathologic understanding and control of varicella-zoster virus infection.
    Asano Y
    Vaccine; 2008 Nov; 26(50):6487-90. PubMed ID: 18694794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and characterization of 20 immunocompetent patients with simultaneous varicella zoster and herpes simplex virus infection.
    Giehl KA; Müller-Sander E; Rottenkolber M; Degitz K; Volkenandt M; Berking C
    J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):722-8. PubMed ID: 18312326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Herpes zoster and meningitis resulting from reactivation of varicella vaccine virus in an immunocompetent child.
    Iyer S; Mittal MK; Hodinka RL
    Ann Emerg Med; 2009 Jun; 53(6):792-5. PubMed ID: 19028409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Varicella zoster vaccines.
    Creed R; Satyaprakash A; Ravanfar P
    Dermatol Ther; 2009; 22(2):143-9. PubMed ID: 19335725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Varicella-zoster virus infections.
    Gershon AA
    Pediatr Rev; 2008 Jan; 29(1):5-10; quiz 11. PubMed ID: 18166616
    [No Abstract]   [Full Text] [Related]  

  • 27. Prevention strategies: herpes zoster, post-herpetic neuralgia and immunogenicity.
    Levin MJ; Schmader K
    Herpes; 2007 Sep; 14 Suppl 2():45-7. PubMed ID: 17939896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigations of the pathogenesis of Varicella zoster virus infection in the SCIDhu mouse model.
    Arvin AM
    Herpes; 2006 Nov; 13(3):75-80. PubMed ID: 17147912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Item 84--Herpesvirus infections in the child and the immunocompetent adult: chickenpox and shingles].
    CEDEF
    Ann Dermatol Venereol; 2012 Oct; 139(11 Suppl):A22-8. PubMed ID: 23176852
    [No Abstract]   [Full Text] [Related]  

  • 30. Herpes zoster with skin lesions and meningitis caused by 2 different genotypes of the Oka varicella-zoster virus vaccine.
    Levin MJ; DeBiasi RL; Bostik V; Schmid DS
    J Infect Dis; 2008 Nov; 198(10):1444-7. PubMed ID: 18826373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Herpes zoster due to Oka vaccine strain of varicella zoster virus in an immunosuppressed child post cord blood transplant.
    Chan Y; Smith D; Sadlon T; Scott JX; Goldwater PN
    J Paediatr Child Health; 2007 Oct; 43(10):713-5. PubMed ID: 17854459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Herpes zoster after varicella vaccination in a healthy young child.
    Obieta MP; Jacinto SS
    Int J Dermatol; 2008 Jun; 47(6):640-1. PubMed ID: 18477170
    [No Abstract]   [Full Text] [Related]  

  • 33. [Varicella and herpes zoster. Epidemiology, physiopathology, diagnosis, development, treatment].
    Perronne C
    Rev Prat; 1996 Oct; 46(16):2009-14. PubMed ID: 8978209
    [No Abstract]   [Full Text] [Related]  

  • 34. The effectiveness of varicella vaccination during an outbreak in a children's day-care center.
    Kiliç A; Unüvar E; Yilmaz C; Yildiz I; Oğuz F; Sidal M
    Vaccine; 2008 Jun; 26(27-28):3371-2. PubMed ID: 18490083
    [No Abstract]   [Full Text] [Related]  

  • 35. The postmarketing safety profile of varicella vaccine.
    Sharrar RG; LaRussa P; Galea SA; Steinberg SP; Sweet AR; Keatley RM; Wells ME; Stephenson WP; Gershon AA
    Vaccine; 2000 Nov; 19(7-8):916-23. PubMed ID: 11115716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Varicella zoster virus: review of its management.
    Mustafa MB; Arduino PG; Porter SR
    J Oral Pathol Med; 2009 Oct; 38(9):673-88. PubMed ID: 19691461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of varicella vaccine on varicella-zoster virus dynamics.
    Schmid DS; Jumaan AO
    Clin Microbiol Rev; 2010 Jan; 23(1):202-17. PubMed ID: 20065330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Varicella immunization and herpes zoster.
    Volpi A
    Herpes; 2005 Dec; 12(3):59. PubMed ID: 16393520
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of fifteen commercial assays for detecting Varicella Zoster virus IgG with reference to a time resolved fluorescence immunoassay (TRFIA) and the performance of two commercial assays for screening sera from immunocompromised individuals.
    Chris Maple PA; Gunn A; Sellwood J; Brown DW; Gray JJ
    J Virol Methods; 2009 Feb; 155(2):143-9. PubMed ID: 18996415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention strategies: experience of varicella vaccination programmes.
    Patrick D
    Herpes; 2007 Sep; 14 Suppl 2():48-51. PubMed ID: 17939897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.